Hospice Care Overlooked for End-of-Life Cancer Care

Hospice Care Overlooked for End-of-Life Cancer Care

End-of-life cancer care, whether decided by doctor or patient, favors intensive treatment that may be shortchanging a person’s chance of greater comfort in their dying days, Dartmouth College researchers said. Too many advanced-cancer patients receive invasive hospital treatments such as feeding tubes while they are dying instead of being directed to hospice and other palliative care that could ease suffering, the Dartmouth Atlas Project said today in a report. The group looked at data for Medicare, the U.S. health plan for the elderly, that showed an increase in cancer patients in intensive care units in the last month of life.The share of cancer patients receiving hospice care has increased to about 61 percent in 2010 from 55 percent in 2003-2007, according to the report. That improvement obscures a more telling statistic: those admitted to hospice in the last three days of life — when it’s too late to provide much comfort — rose 31 percent, said David Goodman, co-principal investigator for Dartmouth Atlas.

“We’re seeing some pretty rapid changes in patterns of care but the move toward the care that most patients prefer is happening very unevenly, at the same time that many patients are receiving more aggressive in-patient care and less effective hospice care,” Goodman said in a telephone interview.

End-of-life cancer care varies widely across the nation, with large differences in the use of intensive care versus palliative care depending on where patients live, the Dartmouth study found. In Manhattan, for example, 43 percent of Medicare patients with cancer died in a hospital, compared with about 11 percent in Mason City, Iowa.

Medicare Policy

Patients with cancer whose illnesses advance despite treatment and find themselves with waning strength and energy should “be cautious about excessive medical care,” Ira Byock, a former director of palliative care at Dartmouth-Hitchcock Medical Center, said in an essay accompanying the study.

“Under the influence of the more-is-better mentality, well-intentioned clinicians and loving families can inadvertently cause people to spend precious, fleeting days at the end of a long illness in hospitals and ICUs, instead of at home or other places they would rather be,” he wrote.

Medicare policy, which requires patients to forgo curative care if they enter hospice, may discourage palliative care, Goodman said. Patients can and should seek palliative care, which is not the same as hospice, even while they’re undergoing treatments aimed at curing their cancer, he said.

“Palliative care in particular has lots of advantages when it’s introduced concurrently with efforts to prolong a patient’s life,” Goodman said. “If it looks like a patient is likely to pass away in weeks or months, it makes sense to have a wider range of options and transitions, and not what is often felt as a black-and-white situation.”

The study examined care in the last six months of life for more than 212,000 Medicare patients. Dartmouth Atlas studies variations in health-care spending and practices across the U.S.

To contact the reporter on this story: Alex Wayne in Washington at awayne3@bloomberg.net

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment